Different approaches but all aiming Abeta: Cytos (partner with NVS) has a peptide vaccine in phase II, Transition Therapeutics (partner with Elan) with a scyllo-inositol, NeuroGenetic, EnVivo, and Satori are all in the gamma secretase modulators area and CoMentis (partner with Astellas) has a BACE inhibitor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.